Last $1.76 USD
Change Today +0.02 / 1.15%
Volume 133.9K
CRIS On Other Exchanges
Symbol
Exchange
Frankfurt
As of 10:16 AM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kenneth I. Kaitin Ph.D.

Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee, Curis, Inc.
AgeTotal Calculated CompensationThis person is connected to 27 board members in 3 different organizations across 3 different industries.

See Board Relationships
61$90,878

Background*

Dr. Kenneth I. Kaitin, Ph.D. serves as a Professor of Medicine, Pharmacology & Experimental Therapeutics at Tufts University School of Medicine and served as its Associate Professor of Medicine. Dr. Kaitin served as an Editor-in-Chief of Drug Information Journal. He is an internationally recognized expert on the science of drug development. He served as the President of the Drug Information Association from 1997 to 1998. He has been a Director of Curis, Inc. since November ...

Read Full Background

Corporate Headquarters*

4 Maguire Road
Lexington, Massachusetts 02421

United States

Phone: 617-503-6500
Fax: 617-503-6501

Board Members Memberships*

2003-Present
Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
2007-2010
Former Director and Chairman of Governance, Nominating & Compliance Committee

Education*

BS
Cornell University
MS
University of Rochester
PhD
University of Rochester

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$35,000
Total Calculated Compensation$90,878
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRIS:US $1.76 USD +0.02

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
$489.3K
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
$555.0K
Michael M. Goldberg M.D., M.B.A.Interim Chief Executive Officer and Director
Navidea Biopharmaceuticals, Inc
--
Rosemary A. Crane Chief Executive Officer, President and Director
MELA Sciences, Inc.
$43.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CURIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.